Does Mounjaro Cause Eczema? Skin Reactions Explained Written by Bolt Pharmacy Published 30/10/2025 Last Updated 16/4/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus, with proven efficacy in glycaemic control and weight reduction. Whilst gastrointestinal side effects are well documented, some patients have questioned […]
Tag Archives: Mounjaro health journey
Does Mounjaro Make Your Pee Yellow? UK Guide Written by Bolt Pharmacy Published 3/11/2025 Last Updated 12/8/2026 Does Mounjaro make your pee yellow? Mounjaro (tirzepatide) is not directly linked to yellow urine as a documented side effect in UK product information. However, patients may notice darker yellow urine due to dehydration caused by the medication’s […]
Mounjaro and Birth Control: Contraception Safety Guide Written byBolt PharmacyPublished31/10/2025Last Updated22/7/2026 Mounjaro (tirzepatide) is a GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes and weight management. For people of reproductive age, understanding how Mounjaro and birth control interact is essential. Tirzepatide slows gastric emptying, which can reduce the absorption of […]
Does Mounjaro Insomnia Go Away? UK Medical Guide Written by Bolt Pharmacy Published 14/10/2025 Last Updated 2/7/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management. While some patients report sleep disturbances when taking Mounjaro, insomnia is not listed as an established adverse […]
Mounjaro and Depo Shot: Safety, Interactions and Guidance Written by Bolt Pharmacy Published 6/11/2025 Last Updated 16/4/2026 Mounjaro (tirzepatide) and Depo-Provera (depot medroxyprogesterone acetate) are commonly prescribed medications that some individuals may use concurrently. Mounjaro is a dual GIP/GLP-1 receptor agonist licensed for type 2 diabetes and weight management, whilst Depo-Provera is a long-acting injectable […]
Digestive Enzymes and Mounjaro: Safety and Management Guide Written by Bolt Pharmacy Published 30/10/2025 Last Updated 14/5/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management. As with many GLP-1-based therapies, gastrointestinal side effects such as nausea, bloating, and altered digestion are common, […]
Does Mounjaro Cause Itching? UK Guide to Tirzepatide Side Effects Written by Bolt Pharmacy Published 6/11/2025 Last Updated 12/8/2026 Does Mounjaro cause itching? Mounjaro (tirzepatide) is a GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes and weight management. Whilst gastrointestinal side effects are most common, some patients report itching during […]
3rd Week on Mounjaro: What to Expect and How to Manage Written by Bolt Pharmacy Published 24/11/2025 Last Updated 12/8/2026 By the third week on Mounjaro (tirzepatide), most patients continue their initial 2.5 mg weekly dose as their body adapts to this dual GIP and GLP-1 receptor agonist. Licensed in the UK exclusively for type […]